Suppr超能文献

相似文献

1
Ovarian/Tubal Pathology in Premenopausal Women with Breast Cancer: A Prospective Study.
J Obstet Gynaecol India. 2025 Apr;75(Suppl 1):113-120. doi: 10.1007/s13224-024-02019-y. Epub 2024 Jul 31.
2
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.
3
Prophylactic mastectomy for the prevention of breast cancer.
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
4
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
5
Interventions for fertility preservation in women with cancer undergoing chemotherapy.
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
6
LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD004562. doi: 10.1002/14651858.CD004562.pub4.
7
Setting the Threshold for Surgical Prevention in Women at Increased Risk of Ovarian Cancer.
Int J Gynecol Cancer. 2018 Jan;28(1):34-42. doi: 10.1097/IGC.0000000000001147.
9
Risk-Reducing Strategies for Ovarian Cancer in Mutation Carriers: A Balancing Act.
Oncologist. 2017 Apr;22(4):450-459. doi: 10.1634/theoncologist.2016-0444. Epub 2017 Mar 17.
10
LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
Cochrane Database Syst Rev. 2008 Oct 8(4):CD004562. doi: 10.1002/14651858.CD004562.pub3.

本文引用的文献

2
GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists.
Ann Surg Oncol. 2022 Oct;29(11):6497-6500. doi: 10.1245/s10434-022-12151-6. Epub 2022 Jul 15.
4
Mainstreaming genetic counseling for testing into oncology clinics - Indian perspective.
Indian J Cancer. 2019 Nov;56(Supplement):S38-S47. doi: 10.4103/ijc.IJC_458_19.
7
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Lancet. 2016 Mar 5;387(10022):945-956. doi: 10.1016/S0140-6736(15)01224-6. Epub 2015 Dec 17.
8
Adjuvant ovarian suppression in premenopausal breast cancer.
N Engl J Med. 2015 Jan 29;372(5):436-46. doi: 10.1056/NEJMoa1412379. Epub 2014 Dec 11.
9
Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.
J Clin Oncol. 2014 Oct 10;32(29):3275-83. doi: 10.1200/JCO.2013.54.1987. Epub 2014 Sep 8.
10
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
N Engl J Med. 2014 Jul 10;371(2):107-18. doi: 10.1056/NEJMoa1404037. Epub 2014 Jun 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验